Home/Filings/4/0001209191-19-044367
4//SEC Filing

Dispersyn Gerrit 4

Accession 0001209191-19-044367

CIK 0001533040other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 8:36 PM ET

Size

5.1 KB

Accession

0001209191-19-044367

Insider Transaction Report

Form 4
Period: 2019-08-01
Dispersyn Gerrit
Chief Development Officer
Transactions
  • Tax Payment

    Common stock, $0.0001 par value

    2019-08-01$0.40/sh1,236$498477,817 total
Footnotes (2)
  • [F1]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]Includes shares of common stock underlying unvested restricted stock units.

Issuer

Phio Pharmaceuticals Corp.

CIK 0001533040

Entity typeother

Related Parties

1
  • filerCIK 0001704417

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 8:36 PM ET
Size
5.1 KB